SAF Protocol 03: GLP-1 Sarcopenia Prevention, 1.2 to 1.6 g/kg Protein Floor & 2.5g-3.0g Leucine mTORC1 Threshold

SAF Protocol 03: GLP-1 Sarcopenia Prevention, 1.2 to 1.6 g/kg Protein Floor, 2.5g to 3.0g Leucine mTORC1 Threshold & Mechanical Load

Skeletal muscle preservation protocol for rapid incretin-mediated weight reduction: without structured protein dosing and mechanical tension, 25% to 40% of total weight lost on GLP-1 therapy can come from lean body mass (Wilding et al. STEP 1 DXA substudy, NEJM 2021, PMID 33567185). SAF Protocol 03 defends resting metabolic rate and glucose disposal via the 1.2 to 1.6 g/kg reference-weight protein floor and per-meal 2.5g to 3.0g L-leucine mTORC1 triggers (PROT-AGE Study Group, PMID 23867520).

1. The Sarcopenia Risk Profile: Why the Bathroom Scale Lies

In the Shared Agency Framework (SAF), crude scale weight is treated as a secondary metric. The primary objective of the clinical partnership is preserving Metabolic Currency (Lean Muscle Mass) while reducing visceral and subcutaneous adipose tissue.

In the STEP 1 DEXA body-composition substudy (Wilding et al., NEJM 2021; PMID: 33567185), approximately 39% to 40% of total weight lost on semaglutide came from lean mass - a pattern seen across all rapid weight-loss modalities when targeted protein and resistance protocols are absent. Because skeletal muscle accounts for roughly 80% of insulin-mediated glucose disposal and anchors resting energy expenditure, losing muscle lowers basal metabolic rate and sets a biological trap for rapid fat regain.

The SAF Body-Composition Standard: A smaller body is a clinical failure if it is a weaker, sarcopenic body. Track waist circumference at the navel, functional strength (grip strength and timed sit-to-stand), and DEXA body composition scans alongside scale weight.

2. Operationalizing Muscle Protein Synthesis: The Protein Floor & Leucine Anchor

When appetite falls by 30% to 50% on GLP-1 or GIP/GLP-1 therapy, protein is frequently the first macronutrient to drop below maintenance thresholds. The SAF protocol locks in three mathematical rules:

Protocol Pillar	Clinical Target & Formula	Execution Guidance & Clinical Caveats
1. The Daily Protein Floor	1.2 g to 1.6 g per kg of reference/adjusted weight Formula: (Weight in lbs ÷ 2.2) × 1.2	Per PROT-AGE guidelines (Bauer et al., PMID: 23867520). For patients with higher starting BMI, calculate using goal or adjusted body weight (typically 60g to 110g/day). Confirm target with prescriber if eGFR is reduced (CKD).
2. The Leucine Anchor (mTORC1)	2.5g to 3.0g of Leucine per meal (~25g to 35g high-quality intact protein)	Required to overcome anabolic resistance and trigger intracellular mTORC1 muscle protein synthesis (Phillips, PMID: 28414324). Plant protein isolates require ~35g to 40g or leucine fortification to match whey/egg leucine density.
3. Protein Pacing & Priming	3 to 4 evenly spaced intakes daily Always eat Protein First	Backloading protein into a large dinner fails on GLP-1 therapy because delayed gastric emptying ends the meal early. Eat protein first at every meal.

3. The Mechanical Load Signal: Movement as Medicine

The human body catabolizes tissue it perceives as unnecessary during an energy deficit. Even with adequate dietary protein, skeletal muscle requires a mechanical contractile signal to activate myofibrillar synthesis (Longland et al., Am J Clin Nutr 2016; PMID: 26817506).

Minimum Effective Dose (MED): Two to three non-consecutive sessions per week of progressive resistance training targeting major compound movement patterns (squat/sit-to-stand, hinge, push, pull, loaded carry) in the 8 to 12 repetition range.
Agency-Driven Modality: Under SAF, exercise is never prescribed as caloric punishment for eating. The patient selects the resistance modality (free weights, machines, bands, or bodyweight progression); the clinician monitors functional strength and recovery.

4. Renal Stewardship & Clear Hydration Pacing

Higher dietary protein density paired with blunted thirst signaling on incretin therapy requires deliberate hydration. Patients target 64+ oz of water and sugar-free electrolytes daily, separated by 20 to 30 minutes from solid protein meals so gastric capacity is preserved for amino acid intake, and verify baseline kidney function (CMP/eGFR) with their prescriber.

Interactive Patient Self-Check · Zero PHI Stored

Interactive 1.2 to 1.6 g/kg Protein Floor & Leucine Anchor Calculator

Without a deliberate protein floor and resistance stimulus, 25% to 39% of weight lost on incretin therapy comes from lean skeletal muscle (STEP 1 DXA sub-study, PMID: 33567185). Calculate your daily muscle-defense targets:

Reference or Target Body Weight (lbs) Meals / Protein Anchors Per Day

Your Personalized Sarcopenia Defense Prescription

Reference Weight: 175 lbs (79.4 kg)
--------------------------------------------------
- Daily Protein Floor (1.2 g/kg): 95 g/day minimum
- Optimal Muscle-Sparing Target (1.6 g/kg): 127 g/day
- Per-Meal Target (4 windows): 24g to 32g protein/window
- mTORC1 Leucine Trigger: 2.5g to 3.0g leucine per meal
- Mechanical Load Signal: 2-3x/week progressive resistance

Open Full Protein Worksheet (Tool 03) → Printable Worksheet PDF →

5. Primary Citations & Printable Worksheet

Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 DEXA substudy). N Engl J Med. 2021;384:989-1002. (PMID: 33567185)
Bauer J et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. (PMID: 23867520)
Phillips SM. Current Concepts and Unresolved Questions in Dietary Protein Requirements and Supplements in Adults. Front Nutr. 2017;4:13. (PMID: 28414324)
Longland TM et al. Higher compared with lower dietary protein during an energy deficit combined with intense exercise promotes greater lean mass gain and fat mass loss. Am J Clin Nutr. 2016;103(3):738-746. (PMID: 26817506)

Download SAF Protocol 03 (PDF) Download Protein & Muscle Worksheet (PDF) Next: SAF Doc 04 (Dopamine & Food Noise) →

Shared Agency Framework (SAF) · Complete 5-Part Patient Biological Series

← The 3-Pillar Framework Hub 01. Cortisol-Willpower Loop 02. Gastric Emptying & Second Brain 03. Sarcopenia & Muscle Defense 04. Dopamine & Food Noise 05. Set Point & Plateaus Open 5 Patient Calculators →

Lean Mass Preservation, mTORC1 Leucine Trigger & Nitrogen Balance Targets

Muscle Defense Parameter	Clinical Target / Formula	Evidence Base (Citation)	Shared Agency Instrument
Daily Protein Floor	1.2 to 1.6 g/kg of reference/target body weight per day	PROT-AGE Study Group (Bauer et al., PMID: 23867520)	Tool 03: Protein & Leucine Calculator
Per-Meal Leucine Anchor	2.5g to 3.0g L-Leucine (~30-40g high-bioavailability protein) per meal	Overcomes anabolic resistance by activating ribosomal mTORC1	Eat protein anchor during the first 10 minutes of every meal
Unguided Lean Loss Risk	Up to 25% to 39% of total weight lost from lean mass if unguided	STEP 1 Semaglutide DXA Sub-Study (Wilding et al., PMID: 33567185)	Combine protein floor with 2-3x/week progressive resistance training
Renal Safety Screen	Baseline & 6-month eGFR + Cystatin C + BUN/Creatinine	Confirms safe hyperfiltration vs. CKD Stage 3b-5 modifications	Tool 01: Advanced Lab Panel Guide

Legacy "Any Weight Loss Is Good Weight Loss" vs. Shared Agency Muscle Defense

Legacy Scale-Only Model

Celebrates Rapid Scale Drops While Losing Muscle

Ignores protein intake during appetite suppression, allowing 25% to 39% of total weight lost to come from metabolically active skeletal muscle - lowering Basal Metabolic Rate (BMR) and priming severe rebound weight regain.

Shared Agency Framework (SAF Guide 03)

1.2-1.6 g/kg Protein Floor + 2.5g-3.0g Leucine Anchor

Protects skeletal muscle as your primary glucose sink and metabolic engine by hitting the 2.5g-3.0g leucine threshold per meal (PROT-AGE PMID: 23867520) alongside 2-3x/week resistance loading.

Frequently Asked Clinical & Biomarker Questions

Standalone, peer-reviewed clinical answers structured for patients, prescribers, and clinical decision support.

How much lean muscle mass is lost during GLP-1 weight loss without a muscle-preservation protocol?

In clinical trial body-composition substudies such as STEP 1 (Semaglutide 2.4 mg, NEJM 2021, PMID 33567185), lean body mass accounted for approximately 25% to 39% of total weight lost when patients were placed on generic caloric deficits without structured leucine-anchored protein targets and resistance training.

Why is the 0.8 g/kg RDA for protein insufficient during active GLP-1 weight reduction?

The 0.8 g/kg/day Recommended Dietary Allowance was established to prevent frank nitrogen deficiency in sedentary adults in energy balance. During an active caloric deficit with suppressed appetite, 1.2 to 1.6 g/kg of reference or goal body weight per day is required to maintain positive muscle protein balance (Bauer et al., PROT-AGE Study Group, PMID 23867520).

What is the Leucine Anchor and how does it activate mTORC1?

L-leucine is the primary branched-chain amino acid that binds Sestrin2 to activate the intracellular mTORC1 ribosomal pathway and initiate muscle protein synthesis (MPS). Triggering MPS requires reaching a bolus threshold of 2.5 to 3.0 grams of leucine in a single feeding window (found in 25 to 35 grams of whey, egg, poultry, fish, lean beef, or leucine-fortified plant protein).

Should patients with chronic kidney disease screen renal function before adopting a 1.2 to 1.6 g/kg protein target?

Yes. Always verify baseline eGFR and serum creatinine on a Comprehensive Metabolic Panel (CMP) with your prescriber before increasing dietary protein, as patients with moderate-to-severe chronic kidney disease (CKD Stages 3 to 5 not on dialysis) require individualized nephrology protein targets.